Preparing your experience, please wait…
K
Guidelines & protocols
HIGHLIGHTS OF THE 2025 AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINE ON PHARMACOLOGIC MANAGEMENT OF ADULTS WITH DYSLIPIDEMIA
Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio
PDF20253 pages183 KB
The 2025 AACE Clinical Practice Guideline provides evidence-based recommendations for the management of dyslipidemia in adults, focusing on the pharmacologic interventions available. It highlights the role of various risk factors, including LDL cholesterol levels, in the development of cardiovascular diseases. The guideline also discusses the need for ongoing research to optimize treatment targets and improve health equity in dyslipidemia management.
No account needed
Discuss clinical evidence & guidelines
Examine in Ask OslerAsk this resource
Answers from this document onlyMore like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Uganda Diabetes Management Guidelines – Summarised (2026)
Same clinical topic · Endocrinology
Kiruddu DKA guidelines
Same clinical topic · Endocrinology
Management of DKA
Same clinical topic · Endocrinology
Pharmacotherapy for Obesity Management: 2025 Guidelines
Same clinical topic · Endocrinology
ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology
Standards of Care in Diabetes 2026
Same clinical topic · Endocrinology
RETINOPATHY, NEUROPATHY, AND FOOT CARE: STANDARDS OF CARE IN DIABETES—2026
Same clinical topic · Endocrinology
6. GLYCEMIC GOALS, HYPOGLYCEMIA, AND HYPERGLYCEMIC CRISES: STANDARDS OF CARE IN DIABETES—2026
Same clinical topic · Endocrinology
2026 ETA GUIDELINE ON INTERFERENCE IN IMMUNOASSAY MEASUREMENTS USED IN ASSESSMENT OF THYROID FUNCTION
Same clinical topic · Endocrinology